We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · December 10, 2019

EBRT and High Dose–Rate Brachytherapy for Intermediate- and High-Risk Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics


Additional Info

International Journal of Radiation Oncology, Biology, Physics
External Beam Radiotherapy (EBRT) and High-Dose Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
Int. J. Radiat. Oncol. Biol. Phys 2019 Oct 11;[EPub Ahead of Print], H Tharmalingam, Y Tsang, A Choudhury, R Alonzi, J Wylie, I Ahmed, A Henry, C Heath, PJ Hoskin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading